May 11, 2012 – The use of single positron emission computed tomography (SPECT)/computed tomography (CT) has been reported to change clinical management in a significant number of thyroid cancer patients according to research presented in the May issue of The Journal of Nuclear Medicine. Information obtained from these scans not only helps determine the need for radioiodine therapy or alterative options, but also impacts the long-term follow-up strategy.

May 11, 2012—CoActiv Medical announces this week at the Health Connect Partners 2012 Radiology and Imaging Center Conference an expanded relationship with PenRad Technologies. The new agreement goes beyond the sales alliance established in November 2011 to now integrate PenRad into EXAM-PACS for seamless delivery of advanced image and information management solutions for women’s imaging.

May 9, 2012 – The College of Healthcare Information Management Executives (CHIME) submitted its comments on the proposed rules for Stage 2 Meaningful Use (MU), calling for more time to allow healthcare organizations to better prepare.

May 9, 2012 - The American Society of Breast Disease (ASBD) is concerned about misleading information in a recent study published in the Journal of the American Medical Association (JAMA), comparing breast brachytherapy to whole breast irradiation (WBI).

May 9, 2012 — Two studies presented at the Society of Surgical Oncology 2012 Annual Cancer Symposium found that the SurgicEye declipseSPECT may improve the accuracy of non-imaging gamma probes by providing 3-D images of the tumor and lymph nodes.